在患有重度抑郁症的患者接受venlafaxine治疗后,habenular体积的变化
Josselin Etienne1,2, Alexandre Boutigny2, Denis J David2
1Service Hospitalo-Universitaire de Psychiatrie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
Psychiatry and clinical neurosciences
|June 13, 2024
概括
在患有重大抑郁症 (MDD) 的患者中,使用venlafaxine的抗抑郁药物治疗显著增加了 habenula 体积. 这种结构性大脑变化发生在治疗三个月后,为MDD提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 放射学 放射学是一门学科.
背景情况:
- 大脑的一个关键区域 - - 控制单氨基中心的habenula,与严重抑郁症 (MDD) 有关.
- 抗抑郁药物治疗对MDD患者大脑膜体积的影响在很大程度上仍未被探索.
- 这项研究调查了在MDD中抗抑郁药治疗后的 Habenular 体积变化.
研究的目的:
- 在被诊断为MDD的患者接受抗抑郁药治疗后,检查 habenular体积的变化.
- 确定观察到的 Habenular 体积的变化是否与 MDD 患者的临床改善相关.
- 为了探索抗抑郁药治疗对 Habenular 体积反应的潜在性别差异.
主要方法:
- 至少一个月没有服用抗抑郁药的50名MDD患者接受了MRI扫描.
- 使用3T核磁共振扫描,手动对 Habenula 体积进行了细分.
- 在使用文拉法辛治疗3个月之前和之后进行了评估.
主要成果:
- 在治疗后观察到总半球体积 (2.3%) 和左半球体积 (3.3%) 的统计学上显著增加.
- 与女性患者相比,男性患者的体积增加更大 (4.8%).
- 在 habenular 体积变化和治疗反应或缓解之间没有发现显著的关联,尽管一些变化与改善的嗅觉愉悦性相关.
结论:
- 在患有抑郁症的患者中,三个月的芬拉法辛治疗导致了 habenular 体积的增加.
- 需要进一步的研究来阐明细胞机制,如增殖或树突变化,这些观察到的体积变化的基础.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
122
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
122
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
369
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
369
01:30Electroconvulsive Therapy
33
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
33
01:25Antidepressant Drugs: Overview
444
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
444
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K